SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale | 2,174 | $8.53 | $18,546.60 | (4%) 60.25K to 58.07K | |
02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-24 | Grant | 25,000 | -- | -- | 71% 35.25K to 60.25K | |
05-Jan-24 4:11 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Jan-24 | Sale (Planned) | 440 | $9.17 | $4,034.80 | (1%) 35.69K to 35.25K | |
05-Jan-24 4:11 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Jan-24 | Sale | 2,069 | $9.48 | $19,612.90 | (5%) 37.76K to 35.69K | |
02-Feb-23 7:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-23 | Grant | 20,250 | -- | -- | 116% 17.51K to 37.76K | |
06-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Jan-23 | Sale (Planned) | 442 | $20.75 | $9,171.50 | (2%) 17.95K to 17.51K | |
06-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 04-Jan-23 | Sale | 2,051 | $20.75 | $42,558.20 | (10%) 20.0K to 17.95K | |
04-Jan-22 10:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Jan-22 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K |